Common and Rare Dermatologic Manifestations Registered in COVID-19 Patients-Reference-Cited by-同舟云学术

Common and Rare Dermatologic Manifestations Registered in COVID-19 Patients

Published:2023-01-04 Issue: Volume: Page:79-98
ISSN:2737-5633
Container-title:Coronaviruses
language:
Short-container-title:

Author:

Boukani Linda Mohammadzadeh¹,Mortezania Zohreh²,Shabestari Alireza Mohammadzadeh³,Eshaghizadeh Parisa⁴,Hosseini Seyyedeh Touran⁵,Daemi Amin⁶,Döğüş Yusuf⁶,Yönden Zafer⁶

Affiliation:

1. Tabriz University of Medical Sciences,Faculty of Medicine,Tabriz,Iran,

2. Shahid Beheshti University of Medical Sciences,Faculty of Medicine,Tehran,Iran,

3. Mashhad University of Medical Sciences,Department of Dental Surgery,Mashhad,Iran,

4. Tabriz University of Medical Sciences,Department of Dental Surgery,Tabriz,Iran,

5. Cukurova University,Department of Biotechnology,Adana,Turkey,

6. Cukurova University,Department of Medical Biochemistry,Adana,Turkey,

Abstract

The novel coronavirus (COVID-19) causes a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has become a pandemic. In spite of several studies, the more time passes, the more symptoms are reported among COVID-19 patients. Surprisingly, numerous dermatological manifestations are also reported. This chapter focuses on the dermatological manifestations caused by COVID-19 infection. We overviewed and classified common and rare dermatological symptoms among COVID-19 patients and their pathophysiological mechanisms. We also discuss appropriate therapeutic management and attitudes, which may provide insights for dealing with similar cases in medical centers.

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference71 articles.

1. Carod-Artal F.J.; Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol 2021,72(11),384-396

2. Potekaev N.N.; Zhukova O.V.; Protsenko D.N.; Demina O.M.; Khlystova E.A.; Bogin V.; Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification. Int J Dermatol 2020,59(8),1000-1009

3. Jamshidi P.; Hajikhani B.; Mirsaeidi M.; Vahidnezhad H.; Dadashi M.; Nasiri M.J.; Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review. Front Med (Lausanne) 2021,8,634208

4. Mirza F.N.; Malik A.A.; Omer S.B.; Sethi A.; Dermatologic manifestations of COVID-19: a comprehensive systematic review. Int J Dermatol 2021,60(4),418-450

5. Najar Nobari N.; Seirafianpour F.; Dodangeh M.; Sadeghzadeh-Bazargan A.; Behrangi E.; Mozafarpoor S.; Goodarzi A.; A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations. Exp Dermatol 2021,30(9),1233-1253